The synergism of hydrogen bond-type ultraviolet absorbers (UVA), such as phenyl salicylate and benzotriazole type UVA, and hindered amine light stabilizers (HALS) was investigated and compared with that of benzophenone type UVA. Phenyl salicylate and benzotriazole type UVA showed a similar synergistic and antagonistic interactions with HALS to those for benzophenone type UVA, but the synergism exceeded the antagonism. The order of their synergism of preventing photooxidation was benzotriazole ＞ phenyl salicylate ＞ benzophenone for UVA. The order and the degree of the synergism agreed completely with those of the regeneration of new UVA by the reaction of UVA quinones, accidentally formed by scavenging peroxy radicals, with HALS. Therefore, such generation is concluded as the essence of synergism of UVA with HALS.
Introduction
gism is based on regenerating phenolic substrates from quinones, originating from the reaction of phenolic anti-The interaction of hydrogen bond-type ultraviolet oxidants with peroxy radicals, by the action of HALS. absorbers (UVA) and hindered amine light stabilizers This synergism is more remarkable for benzophenone (HALS) is recognized as a type of synergism, the mech-type UVA than that of BHT and the above-mentioned anism of which has not been comprehensively and antagonism. Therefore, benzophenone type UVA has quantitatively discussed 1)～4) . Previously, we explained apparent synergism with HALS. the synergistic interaction of HALS and benzophenone
The third approach is the estimation of the essential type UVA semi-quantitatively 4), 5) .
functions of UVA and HALS based on the photo-Such interactions should be investigated from at least antioxidant ability, which is assessed by comparing the three approaches 5) . The first approach is to examine the antioxidant ability of a combination of HALS and UVA functions of HALS in the presence of UVA. HALS with that of each additive. have many functions as multi-functional additives, but
The present study investigated whether these the hydroperoxide decomposition ability of HALS is approaches for benzophenone type UVA are applicable the best index to evaluate the above-mentioned inter-to other hydrogen bond-type UVA, benzotriazole and action, because this reflects the disadvantages of HALS. phenyl salicylate type UVA, to clarify the order of inter-That is to say, HALS rapidly form HALS nitrosonium action (synergism) of hydrogen bond-type UVA with with the decomposition of hydroperoxides in the pres-HALS. ence of proton-donating substrates such as phenols and hydrogen bond-type UVA. The HALS nitrosonium 2. Experimental decomposes hydroperoxides homolytically to accelerate the oxidation or degradation of materials, and oxi-2. 1. Reagents dizes a phenol to quinone. Therefore, this approach 2. Aluminum oxide (6.65 g, 0.05 mol) and methane sulfonic acid (25 g) were added to benzoic acid (6.10 g, 0.05 mol) and hydroquinone (5.51 g, 0.05 mol), and the mixture was stirred for 1.5 h at 140℃. The reaction solution was cooled and extracted with ethyl ether after the addition of diluted hydrochloric acid. The extract was washed with a saturated aqueous sodium hydrogen carbonate solution, water, and saturated saline, then dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated, refined by a column chromatography (stationary phase: silica gel, eluent: methylene chloride/ethyl acetate＝9/1), and recrystallized from carbon tetrachloride. The product was obtained as yellow crystals. Yield: 1.02 g (9.6％) and melting point: 121.8-122.4℃. _ FT-IR (KBr): 3298 cm -1 ( OH), 1714.6 cm -1 (C=O) and 875.6 cm -1 (C6H6). 1 H-NMR (CDCl3, TMS): 11.6 ppm (1H, 1 _ OH), 8.0-6.9 ppm (2H, C6H4), and 5.0 ppm (1H, 4 _ OH).
1. 1. Synthesis of 2-Benzoyl-p-quinone
in dry ether OH O C 2,5-Dihydroxybenzophenone (0.5 g) was dissolved in dry ethyl ether (40 ml). Silver (I) oxide (5 g) and anhydrous sodium sulfate (5 g) were added. The mixture was stirred for 3 h at room temperature in the dark. The reaction solution was filtered, and the resulting solution was distilled off in vacuo to give brown crystals. Yield: 0.43 g (86％) and melting point: 79.8-80.3℃. FT-IR (KBr): 3298 cm -1 ( _ OH disappeared), 1651 cm -1 (C=O), and 1596.9 cm -1 (C=C). Triphenyl phosphite (20 g, 0.064 mol) was added to 2,5-dihydroxybenzoic acid (4.93 g, 0.032 mol), then tri-fluoromethane sulfonic acid (0.2 g) was added, and the mixture was stirred for one day at room temperature. Ethyl ether was added to the reaction solution, and the mixture was washed with saturated aqueous sodium hydrogen carbonate solution, distilled water, and saturated saline, then dried over anhydrous sodium sulfate, and filtered. Triphenyl phoshite was removed using hexane after the solution was evaporated in vacuo. The crude product was purified by a column chromatography (stationary phase: silica gel, eluent: methylene chloride/acetone＝10/1), and was recrystallized from chloroform-hexane. The product was white crystals. Yield 
1. 1. 3. Synthesis of Phenyl 5-Hydroxysalicylate

1. 1. 5. Synthesis of 4-Methoxy-2-(2'-nitrophenylazo)-phenol
o-Nitroaniline (6.90 g, 0.05 mol) was dissolved in conc. HCl (25 ml) and cooled at about -2 to -3℃, then 5 N NaNO2 solution (12.5 ml) was added dropwise slowly to obtain a diazonium salt solution. p-Methoxyphenol (6.20 g, 0.05 mol) in 10％ NaOH solution (40 ml) was added, and the mixiture was stirred for 4 h in an iced bath, then filtered with suction, and the filtrate was dissolved in methylene chloride. The solution was evaporated in vacuo to give a dark red viscous residue which was purified by a column chromatography (stationary phase: silica gel, eluent: methylene chloride), and was recrystallized from ethanol. The product was 4-Methoxy-2-(2'-nitrophenylazo)-phenol (3.48 g, 0.013 mol) was dissolved in ethanol (50 ml) and 4N aqueous NaOH solution (50 ml), thiourea dioxide (4.28 g) was added, and the mixture was refluxed for 15 min at 80℃. Then, thiourea dioxide (2.14 g) was added, and again refluxed for about 30 min. The reaction solution was cooled, and was extracted with ethyl ether after the addition of diluted hydrochloric acid. The extract was washed with saturated aqueous sodium hydrogen carbonate solution, distilled water, and saturated saline. This was dried over anhydrous sodium sulfate, and filtered. After the vacuum evaporation, the residue was purified by a column chromatography (stationary phase: silica gel, eluent: methylene chloride), and was recrystallized from hexane. The product was yellow crystal. Yield 2-(2'-Hydroxy-5'-methoxy)-phenyl-benzotriazole (1.5 g, 0.0062 mol) was dissolved in methylene chloride, and cooled for 10 min. BBr3 (6 mol/l)/CH2Cl2 (12 ml) was added, and the mixture was stirred for 10 min. After the formation of a yellow solid, the mixture was stirred for additional 90 min. The reaction solution was poured onto ice, and basified with 5％ Na2CO3 solution. The methylene chloride was evaporated off and the residue was acidified with 1 N HCl. A yellow precipitate was collected by suction filtration, purified by a column chromatography (stationary phase: silica gel, eluent: methylene chloride), and recrystallized from ethanol-hexane. The product was yellow crystal. Yield: 1.39 g (98.6％) and melting point: 211.1-211.4℃. FT-IR (KBr): 3313.5 cm -1 ( _ OH), 2835.2 cm -1 ( _ OCH3 disappeared). 1H-NMR (DMSO-d6, TMS): 6.9-8.2 ppm (7H, benzene), 9.4 ppm (1H, 4 _ OH), and 9.9 ppm (1H, 1 _ OH). 
1. HALS Derivatives
Bis(2,2,6,6-tetramethyl-4-piperidinyl) sebacate (ADK stab LA-77, ADEKA Corp.) designated as HALS in this study was refined by a general method. The other HALS derivatives, for instance, bis(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl) sebacate (HALS NO), bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) sebacate (HALS NOH), 4-acetoxy-2,2,6,6-tetramethylpiperidine (Ac-HALS), 4-hydroxy-1-oxy-2,2,6,6-tetramethylpiperidine (HO-HALS NO), 4-acetoxy-1-oxy-2,2,6,6-tetramethylpiperidine (Ac-HALS NO), 4-acetoxy-1-oxy-2,2,6,6-tetramethylpiperidinium nitrate/ nitrite (Ac-HALS N ＋ ＝O NO3 -/NO2 -) were synthesized according to the procedures described previously 6) .
1. 3. Other Reagents
Cumene hydroperoxide (CHP) (Nacalai Tesque, Inc.) was used as the hydroperoxide. Chlorobenzene (GODO Solvents. Co.) was purified as a solvent by a general method. 2-Hydroxybenzophenone (Tokyo Chemical Industry Co., Ltd.) as the ultraviolet absorber and 3,5di-t-butyl-4-hydroxy-toluene (BHT) (Tokyo Chemical Industry Co., Ltd.) as the phenol were refined by conventional methods.
Styrene was distilled in vacuo just before use, and azo-bis-isobutyronitrile (AIBN) was recrystallized from ethanol.
Procedures 1. Decomposition of CHP
The HALS, CHP, and UVA or phenol were dissolved in oxygen-free chlorobenzene in predetermined amounts, and allowed to react at 120℃ in an oil bath with stirring under nitrogen. Aliquots were sampled at intervals to determine the decomposed amount of CHP and generated products by iodometry and GC-mass spectrometer (GC-MS), respectively.
Measurement of Photo-antioxidant Ability
The photooxidation reaction of styrene was performed with irradiating UV rays above 290 nm. The light source was a high pressure mercury lamp (500 W, made by Ushio Co.). The oxidation was followed by measuring the amount of consumed oxygen by a pressure transducer.
3. Reaction of Quinone and HALS
Benzoquinone and HALS NOH or the corresponding hydroquinone and HALS NO were dissolved in chlorobenzene, and were allowed to react at 50℃ under nitrogen. The generated hydroquinone or benzoquinone, respectively, was analyzed quantitatively with a VIS-UV spectrometer.
4. Iodometry
Carbon dioxide was bubbled into 10％ acetic acidisopropyl alcohol solution for two min to purge the dissolved oxygen. Saturated potassium iodide solution (0.5 ml) and the sample (1 ml) were added. This solution was stirred at 95℃ in an oil bath under carbon dioxide atmosphere to liberate iodine, which was titrated with N/1000 sodium thiosulfate.
5. Instrumental Analyses
The GC was a Shimazu GC-17A or GC-14B with a hydrogen flame ionizing detector (FID). The GC column used was 400-1HT (Quadrex Corp.). The GC-MS was a Shimazu QP5050A and was used for the identification of additives and their derivatives. The same column was used.
Results and Discussion
1. Antagonism of Hydrogen Bond-type UVA
with HALS As described previously 5) , the antagonism of HALS with hydrogen bond-type UVA is directly related to HALS nitrosonium, the formation of which is promoted by a proton-donation of UVA, and which takes part in both a homolytic decomposition of hydroperoxides and a useless consumption of UVA.
First of all, such interactions of HALS with hydrogen bond-type UVA, such as phenyl salicylate and benzotriazole type UVA, were examined in CHP decomposition reaction. Figure 1 illustrates the effect of UVA on the homolytic decomposition of CHP by HALS, together with that of UVA-1. UVA-2 and UVA-3 in combination with HALS NH showed longer induction Therefore, UVA-2 and -3 generate HALS nitrosonium with more difficulty than UVA-1. This fact may be ascribed to the relative intramolecular hydrogen bond strengths of the UVA. Interestingly, the induction period of CHP decomposition by the combination of UVA-3 and HALS NH was longer compared with that of only HALS. The formation of HALS nitrosonium must first form the HALS salt with UVA, followed by the reaction with hydroperoxides 6) . Therefore, the longer induction period shown by UVA-3 may mean that it does not function as a proton donor or prevents a HALS nitrosonium forming for some unidentified reason. Thus, the interaction of HALS and hydrogen bond-type UVA is judged as slightly high antagonism for UVA-1, slight antagonism for UVA-2, and synergism for UVA-3 in CHP decomposition.
There is another mechanism of antagonism of useless consumption of UVA by HALS nitrosonium. However a separately synthesized HALS nitrosonium did not oxidize UVA-2 and UVA-3 at all, although it oxidized UVA-1 in a trace amount. Therefore, such antagonism can be disregarded in this study.
2. Synergism of Hydrogen Bond-type UVA with
HALS As mentioned before, the synergism of UVA with HALS was directly estimated by the reduction of a quinone of UVA with HALS NOH kinetically as shown below: This reaction was examined under diffused light, though the forward reaction is promoted by UV radiation. Figure 2 illustrates the result of the equilibrium reaction concerning UVA-3, for example, obtained by measuring the increase or decrease in the absorption at λmax 311 nm of UVA-3. The rate constants of forward and reverse reactions and finally the equilibrium constant (K＝kQ,NOH/k-Q,NO) can be calculated. UVA-2 also showed similar results. Table 1 shows the rate constants and equilibrium constants for the three hydrogen bond-type UVA together with those of BHT.
Generally speaking, hydrogen bond-type UVA showed much faster for the forward reaction than BHT, and only slightly faster reverse reaction. Therefore, the equilibrium constants of UVA are remarkably higher than the constant of BHT. Since the quinone of UVA sometimes enhances photooxidation by absorbing UV rays, the higher equilibrium constant indicates the better synergism of hydrogen bond-type UVA with HALS is in the order of UVA-2＞ UVA-3＞ UVA-1. Such synergism is based on HALS NOH, but similar for HALS NH, although the synergism was less.
Photo-antioxidant Ability of UVA in the
Presence of HALS In practical photo-stabilization, it is important to inhibit the photooxidation, which occurs and proceeds under the effects of both antagonism and synergism. Therefore, the actually observed synergism of UVA with HALS must be elucidated by comparing the synergistic effects during photooxidation performed using a combination of both components.
In photooxidation, a quinone is formed from UVA accidentially by reaction with chain carriers, such as peroxy radicals, and is excited by absorbing UV rays, which may sometimes promote the photooxidation. However, no adverse effect appears if such a quinone does not form by the action of HALS, or if such an excited quinone converts into the corresponding hydroquinone by the reaction with HALS NOH as described in 3. 2., which can function again as a new UVA. That is, synergism will be observed. Figure 3 illustrates the interaction of various combinations of UVA-2 with a peroxy radical scavenger, to examine whether HALS can control the formation of UVA quinone due to their preferentially scavenging peroxy radicals. As widely recognized, the broken line in the figure represents the total contribution of the individual components, indicating no interaction. If the observed effect is more than the total contribution, that is, the observed curve is below the broken line, this effect is referred to as synergism. Thus, UVA-2 exhibits a considerable synergism with HALS NOH or HALS NH. The most important function of UVA and HALS is to prevent photooxidation involving a radical chain reactions. Assuming that the observed synergism is based on the chain carrier-scavenging ability of HALS, a combination of UVA with HALS NO or BHT with much higher radical scavenging ability than HALS NOH, would show strikingly higher synergism. However, this combination actually showed no interaction. Instead, UVA-2 showed slight antagonism by promoting photooxidation in combination with a powerful radical scavenger BHT. These results indicate that the synergistic effect of UVA with HALS is not based on the radical-scavenging ability of HALS. Therefore, Fig. 3 does not support the idea that HALS prevents loss of UVA function by scavenging peroxy radicals 1) . UVA-1 and UVA-3 also showed similar interactions with HALS and the derivatives, although the synergistic degree depended on the type of UVA. Figure 4 illustrates the synergism of various combinations of HALS NOH with hydrogen bond-type UVA in photooxidation reaction. The synergistic effect of each combination can be estimated by the area between the curve and broken line. The synergism is in the order of UVA-2≫ UVA-3＞ UVA-1 for HALS NOH. Figure 5 also shows the synergism of HALS NOH with UVA quinone. The vertical axis shows the photoantioxidant ability, and the horizontal axis shows the concentration ratio of UVA quinone and HALS: the total concentration of the components was fixed at 10 -4 mol/l). HALS and UVA quinone independently seem to hardly affect photooxidation, but together demonstrate a considerable photoantioxidant activity. This synergism is based on the regeneration of a new UVA from a quinone ( Table 1) . Table 2 indicates the ratio, based on 1.00 for UVA-1, of such synergism of UVA with HALS for photooxidations. The synergism ratios are in surprisingly good agreement, although a defference between HALS NH and HALS NOH was observed, probably depending on the easiness of HALS NOH formation from HALS NH. Therefore, the antiphotooxidant synergism of UVA with HALS depends on the regeneration of a new UVA from UVA quinone by HALS. Whether a regenerated UVA shows additional photoantioxidant ability was also examined. Figure 6 compares the synergistic effects of a combination of 2-benzotriazolyl-p-quinone with HALS NH or HALS NOH together with the antioxidant activity of 2-(2',5'dihydroxy)-phenyl-benzotriazole as the regenerated UVA. The curve for the combination of 2-benzotriazolyl-p-quinone with HALS NOH is copied from Fig. 5. Figure 6 shows HALS NH, in place of HALS NOH, also working synergistically, although the synergistic effect was much lower than that of HALS NOH. On the other hand, the regenerated UVA of 2-(2',5'dihydroxy)-phenyl-benzotriazole, in the same amount as 2-benzotriazolyl-p-quinone in the previous combination, also showed anti-photooxidant activity. Interestingly, the degree of such activity of 2-(2',5'dihydroxy)-phenyl-benzotriazole coincided almost with that of the combination of 2-benzotriazolyl-p-quinone with HALS NOH to 50％ of the horizontal axis scale. Above 50％, the synergism of the combination decreases gradually with the decrease of the regenerated amount of 2-(2',5'-dihydroxy)-phenyl-benzotriazole due to the lower amount of HALS NOH. This phenomenon indicates that the regenerated UVA is 2-(2',5'dihydroxy)-phenyl-benzotriazole or the equivalent, which shows a considerable photo-antioxidant ability, resulting in the synergism of UVA-2 with HALS, and also suggests that the essence of synergism of UVA is regeneration of new UVA from UVA quinone by HALS.
